Copyright © 1995 by the European Society of Cardiology.
© 1995 The European Society of Cardiology
Prevention of bacterial endocarditis in Germany
Herzzentrum Bad Krozingen Germany
Correspondence: Christa Gohlke-Bärwolf, MD, Herzzentrum Bad Krozingen, Südring 15, D-79189 Bad Krozingen, Germany.
The goal of this study was to assess the current practice of endocarditis prophylaxis in Germany. We conducted a survey using a standardized questionnaire, which was sent to 100 hospital cardiologists, to 430 cardiologists in office practice and to 389 dentists and oral surgeons. In addition, 364 patients with valvular or congenital heart disease were interviewed in our outpatient clinic.
Seventy five percent of cardiologists informed their patients by both written and oral instructions. Half recommended the use of penicillin, according to the German Society of Cardiology, while the rest followed recommendations of other societies. Sixty-three percent of patients who had undergone a procedure requiring prophylaxis against bacterial endocarditis within the year prior to the questionnaire, had actually received it. This is higher than previously reported, but is far from acceptable.
The indications for prevention of endocarditis, as seen by the dentists, deviated markedly from official recommendations. Although 77% administered antibiotics themselves, in only 57% did the type of prophylaxis applied correspond to one of the available recommendations.
Recommendations on the prevention of bacterial endocarditis are not well known by dentists and oral surgeons who perform procedures for which it is indicated. Further patient- and physician-oriented strategies are urgently needed to improve compliance with prevention of endocarditis in Germany.
Key Words: Prevention of bacterial endocarditis endocarditis prophylaxis practice of bacterial endocarditis prophylaxis survey of practice compliance with endocarditis prophylaxis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Ikeda, A. He, S. W. Kong, J. Lu, R. Bejar, N. Bodyak, K.-H. Lee, Q. Ma, P. M. Kang, T. R. Golub, et al. MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes Mol. Cell. Biol., April 15, 2009; 29(8): 2193 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bisping, S. Ikeda, S. W. Kong, O. Tarnavski, N. Bodyak, J. R. McMullen, S. Rajagopal, J. K. Son, Q. Ma, Z. Springer, et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure PNAS, September 26, 2006; 103(39): 14471 - 14476. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Tornos, B Iung, G Permanyer-Miralda, G Baron, F Delahaye, C. Gohlke-Barwolf, E G Butchart, P Ravaud, and A Vahanian Infective endocarditis in Europe: lessons from the Euro heart survey Heart, May 1, 2005; 91(5): 571 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Berger and R Pacher The role of the endothelin system in myocardial infarction--new therapeutic targets? Eur. Heart J., February 2, 2003; 24(4): 294 - 296. [Full Text] [PDF] |
||||
![]() |
G. Pons-Llado, M. Ballester, X. Borras, F. Carreras, I. Carrio, J. Lopez-Contreras, A. Roca-Cusachs, J. Marrugat, and J. Narula Myocardial cell damage in human hypertension J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2198 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Rossi, A. Sacchetto, E. Pavan, P. Palatini, G. R. Graniero, C. Canali, and A. C. Pessina Remodeling of the Left Ventricle in Primary Aldosteronism Due to Conn's Adenoma Circulation, March 18, 1997; 95(6): 1471 - 1478. [Abstract] [Full Text] |
||||
![]() |
G. P. Rossi, A. Sacchetto, P. Visentin, C. Canali, G. R. Graniero, P. Palatini, and A. C. Pessina Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism Hypertension, May 1, 1996; 27(5): 1039 - 1045. [Abstract] [Full Text] |
||||






